Company Filing History:
Years Active: 2022-2025
Title: Ranjeet Sinha: Innovator in Cellular Therapy
Introduction
Ranjeet Sinha is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of cellular therapy. With a total of four patents to his name, he has made remarkable advancements in the preparation and cultivation of immune cells for therapeutic applications.
Latest Patents
Among his latest patents is a method for preparing mononuclear cell-derived NK cells. This innovative approach allows for the preparation of cord blood or peripheral blood NK cells from whole blood mononuclear cells without the need to isolate CD34+ hematopoietic stem cells or NK cells, and without requiring a feeder layer. The methods utilize an enrichment process involving anti-CD16 agonist antibodies, anti-CD3 antibodies, and N-803. Notably, these processes are designed to be adaptable into a fully automated production process, referred to as GMP in a box. Another significant patent involves generating CIK NKT cells from cord blood, which includes methods and customized media compositions for culturing these specialized immune cells.
Career Highlights
Ranjeet Sinha is currently associated with ImmunityBio, Inc., where he continues to push the boundaries of cellular therapy. His work focuses on developing innovative solutions that enhance the efficacy of immune cell therapies.
Collaborations
He collaborates with notable colleagues such as Rohit Duggal and Wenzhao Li, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Ranjeet Sinha's work in cellular therapy exemplifies the impact of innovative thinking in the medical field. His patents and ongoing research are paving the way for new therapeutic approaches that could significantly improve patient outcomes.